Back to Results
First PageMeta Content
Prescription Drug User Fee Act / Premarket approval / Medical device / Center for Devices and Radiological Health / Abbreviated New Drug Application / Investigational Device Exemption / New Drug Application / Humanitarian Device Exemption / Center for Biologics Evaluation and Research / Food and Drug Administration / Medicine / Health


Final Dispute Resolution Guidance Document - Submission and Resolution of Formal Disputes Regarding the Timeliness of Premarket Review of a Combination Product
Add to Reading List

Open Document

File Size: 39,09 KB

Share Result on Facebook

City

Rockville / /

Company

Center / /

/

Event

Person Communication and Meetings / FDA Phase / /

Facility

Rockville Pike / /

/

IndustryTerm

marketing applications / noncombination products / drug-biologic and device-biologic combination products / biological product premarket applications / combination product / biological product / non-combination products / humanitarian use devices / device applications / premarket applications / combination products / license applications / /

MedicalCondition

deficiency / /

Movie

Standard Operating Procedure / /

Organization

U.S. Department of Health and Human Services / Congress / Food and Drug Administration office of Combination Products Contains Nonbinding Recommendations TABLE OF CONTENTS I. Introduction / Ombudsman Center for Devices and Radiological Health / Food and Drug Administration / FDA Center / office of Combination Products / FDA / Ombudsman Center for Biologics Evaluation / /

Person

Warren Rumble Ombudsman / Sheryl Lard-Whiteford / Les Weinstein / /

/

Position

Director the Division / Commissioner / Director of the reviewing division / /

Product

Investigational New Drug / New Drug / /

ProvinceOrState

Maryland / /

URL

www.fda.gov/cber/gdlns.dispute.pdf / http /

SocialTag